Core Insights - Inotiv, Inc. is actively participating in several upcoming healthcare conferences, showcasing its commitment to engaging with institutional investors and stakeholders in the healthcare sector [1][2]. Group 1: Conference Participation - Inotiv's President and CEO, Robert Leasure Jr., and CFO, Beth Taylor, will represent the company at the UBS Global Healthcare Conference on November 10-11, 2025, in Palm Beach Gardens, FL, focusing on one-on-one institutional investor meetings [2]. - The company will also present at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 4:00 PM GMT/11:00 AM ET, which will include a presentation and one-on-one meetings [2]. - Additionally, Beth Taylor will participate in the Craig-Hallum Alpha Select Conference in New York, NY, on November 18, 2025, which will also be focused on one-on-one institutional investor meetings [2]. Group 2: Company Overview - Inotiv, Inc. is a leading contract research organization that specializes in nonclinical and analytical drug discovery and development services, as well as research models and related products [3]. - The company's services aim to enhance the efficiency and data quality of drug and medical device development while reducing associated costs [3]. - Inotiv is dedicated to supporting research and development objectives, contributing to the advancement of healthcare and safety [3].